Lallemand targets children and teenagers with new probiotics range


29 Aug 2017 --- Lallemand Health Solutions is to unveil its range of probiotics for children and teenagers at Supply Side West, held from 25 to 29 September. The company offers specific probiotic strains and formulations combined with specifically designed delivery forms and flavors to target the needs of children, teenagers and health conscious parents.
Three key areas can be addressed with well documented probiotic strains: immune defenses, stress and oral health. This approach will be presented in more details at the Probiotics Resource Center on 27 September at 2:40 by Isabelle Champié.

“The benefits of probiotics on gut health and immunity [are] now well documented in a preventive approach, through a balance of the gut microflora,” Bérengère Feuz, Lallemand’s Marketing Manager, tells NutritionInsight. “In the area of stress, there is some evidence of specific strains’ effects on physiological and psychological signs of stress. The oral cavity (mouth, gum, teeth) harbors rich microflora, and some probiotics have shown benefits on prevention of dental plaque formation, for example.”

“In our probiotic portfolio, we have identified specific strains and formulations documented for each of these areas by in vitro data on their modes of action and clinical data,” Feuz adds.

This new development comes as both the US and Canadian authorities have approved Lallemand Health Solutions’ formula ProbioKid and three key probiotic strains for use in young children (US GRAS status for infants and children; Health Canada’s approval for children from 3 months old with immunity health claims).

The company will also showcase its range of complete probiotic solutions for other specific areas, namely gastro intestinal health, immunity, stress and mood balance (brain gut axis), women’s health, oral health and active people.

A mature microbiota is achieved after three years old, recent studies have demonstrated. Yet kids and teens face specific challenges where probiotics can play a role.

“We have identified and worked on specific areas: first and above all, natural defenses,” Feuz tells NutritionInsight of these challenges. “Immunity clearly improves with [age] and [in the first years of life] children are prone to common infections. Gut discomfort is also frequent, especially in teenagers; in children, occasional constipation is the most common disorder. Diet imbalance [like poor fruit/veg intake] is also common, especially in teens, and it is proven to have a direct effect on microflora composition.”

“The other areas we have identified more specifically in teens are stress (and with the increased data on [the gut-brain] axis we know the microbiota is involved there) and skin health […] it has been shown that 54 percent of individuals with skin imperfection have significant alterations in the gut flora,” Feuz adds. “And last, oral health: as kids are growing, dental hygiene is not always properly implemented. Moreover, it has been shown that teens are more prone to dental/gum health issues.”

Speaking about Lallemand’s upcoming R&D goals, Feuz says: “We [are continuing] work in various areas, as the more we learn about the microflora and probiotics the more potential arise[s]. We [are looking] into innovative areas, for example, the gut-brain axis, but we [are also not losing] sight of probiotics’ primary area of evidence, gut health. For example, in children: [at the end of] 2013 we started a large-scale multicentric study led by Dr. Stephen Freedman of the University of Calgary and Alberta Children’s Hospital Research Institute, involving as many as 900 children. It aims to evaluate the efficacy of Lacidofil in the treatment of acute gastroenteritis in children admitted to the emergency department. This long-term study was recently completed, and we are now expecting the results.”

By Lucy Gunn and Paul Creasy

To contact our editorial team please email us at

Lallemand Health Solutions


Lallemand Health Solutions (LHS) consolidates the internationally recognized probiotic manufacturers Institut Rosell and Harmonium International. 

Backed by a rich history and 80 years of expertise in probiotic research and development, Lallemand Health Solutions offers a full line of ready-to-market probiotic formula and helps its partners designing their own custom & complex formulations using Harmonium, LAFTI® or Rosell Probiotic strains together with our proprietary protective technologies. Because, from the lab to the shelf, LHS controls the overall manufacturing process of its products, the company can ensure customers are receiving the highest quality standard of probiotic formulation. Cooperation spells success: we provide our partners with the full support they need to develop, register, and market their products in their own market, making of Lallemand Health Solutions a complete probiotic solutions provider.

Lallemand Health Solutions is covering more than 30 countries across five continents ready to service your probiotic needs.


Related Articles

Nutrition & Health News

Weekly Digest: Probiotics reduce bone loss in older women, Optibiotix expands reach in Italy

22 Jun 2018 --- This week in nutrition, Australian Whole Grain Week launched a new diet database in the hope to enhance healthy diets across the country. In research news, UK scientists warn that the normalization of plus-size body shapes may undermine obesity reduction efforts, while probiotics were found to have a significant protective effect for the bones of older women, and further research found that four cups of coffee seemed to protect the heart. Optimum Nutrition and Faber embarked on a campaign to improve American travel snacking habits and Optibiotix and Alfasigma partnered to commercialize Optibiotix's probiotic supplement in Italy. Lastly, this year’s Institute of Food Technologist (IFT18) in Chicago, US, will see NZMP launching a new milk protein ingredient and Lycored delivering some excitement on the floor with “culinary art.”

Nutrition & Health News

“Postbiotics” & smart toilet paper: Future platforms in digestive health?

22 Jun 2018 --- “Postbiotics” – the metabolic byproducts produced by our gut bacteria – and even smart toilet paper are some of the ideas within digestive health put forward following novel research at King's College London into the function of gut bacteria. Linked to a range of health-related conditions, the gut microbiome has been a topic of growing interest. However, although there is an established list of gut bacteria, their function in the gut has remained reasonably unknown. The researchers have set out to create a database of fecal metabolites – compounds produced by the gut microbiome – in an attempt to shed light on the relationship between what we eat, the way it is processed by our gut microbes and how we accumulate abdominal fat. 

Nutrition & Health News

Zero proof that probiotics can ease your anxiety, research reveals

21 Jun 2018 --- Those hoping to alleviate their anxiety with the use of probiotics should probably put down that yogurt spoon or supplement bottle and call a professional instead. This is according to researchers from the University of Kansas who reviewed available research, finding evidence that probiotics can reduce anxiety in rodents, but not in humans. The researchers reviewed data from 22 preclinical studies involving 743 animals and 14 clinical studies of 1,527 individuals, and found that probiotics did “not significantly reduce symptoms of anxiety in humans and did not differentially affect clinical and healthy human samples.”

Business News

Probiotic expansion: General Mills leads investment in GoodBelly parent

21 Jun 2018 --- General Mills' venture arm, 301 Inc., is leading a US$12 million round in funding in NextFoods the parent company of GoodBelly Probiotics. Additional capital is coming from existing investors, including Emil Capital Partners. NextFoods was founded in 2007 by Todd Beckman and Steve Demos, who founded WhiteWave Foods, the owner of Silk plant-based milk.

Nutrition & Health News

DuPont microbiome venture inks third partnership on probiotics

21 Jun 2018 --- A new collaboration with Institut National de la Recherche Agronomique (INRA) Micalis-MGP will concentrate on DuPont’s probiotic strains and the understanding of these microbes’ mechanism of action on human health. The move is hoped to continue DuPonts Microbiome Venture capacity building – through strategic partnerships – in microbiome innovation.

More Articles